Published in Lancet on October 16, 1976
The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71
Familial cerebral amyloidosis and spongiform encephalopathy. J Neurol Neurosurg Psychiatry (1982) 1.19
Manifest absurdity. Br Med J (1976) 0.75
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med (1968) 4.28
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun (1982) 3.22
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol (1992) 2.50
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol (1975) 2.39
Experimental lead paint poisoning in nonhuman primates. I. Clinical signs and course. J Med Primatol (1976) 2.37
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys. Virology (1989) 2.32
Is chronic hepatitis B being undertreated in the United States? J Viral Hepat (2010) 2.24
Australia antigen and acute viral hepatitis. Ann Intern Med (1969) 2.20
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J Virol (1990) 2.09
Evaluation of avian-human reassortant influenza A/Washington/897/80 x A/Pintail/119/79 virus in monkeys and adult volunteers. J Clin Microbiol (1986) 2.06
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA (1968) 1.94
Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene (1993) 1.91
Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys. Science (1982) 1.86
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A (1969) 1.84
Australia antigen and hepatitis. JAMA (1969) 1.81
Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1969) 1.77
Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses. J Infect Dis (1984) 1.77
Experimental respiratory syncytial virus infection of four species of primates. J Med Virol (1977) 1.74
Australia antigen as a hepatitis virus. Variation in host response. Am J Med (1970) 1.69
Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology (1981) 1.67
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet (1975) 1.62
Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science (1978) 1.60
Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat (2008) 1.58
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. J Infect Dis (1972) 1.57
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Sex distribution of Australia antigen. Arch Intern Med (1972) 1.52
Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys. Virus Res (1992) 1.51
Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys. Infect Immun (1980) 1.51
Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med (1979) 1.50
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. J Med Primatol (1994) 1.45
Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus. Proc Natl Acad Sci U S A (1983) 1.42
A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. Virus Res (1990) 1.42
Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness. J Med Virol (1978) 1.42
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Cholecystokinin and gastrin levels are not elevated in human pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.39
Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J Virol (1994) 1.39
Induction of diarrhea in colostrum-deprived newborn rhesus monkeys with the human reovirus-like agent of infantile gastroenteritis. Arch Virol (1976) 1.38
Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J Infect Dis (1988) 1.38
Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med (1981) 1.36
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci U S A (1992) 1.35
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun (1983) 1.35
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A (1989) 1.34
Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infect Immun (1984) 1.34
Duck hepatitis B virus and liver diseases. Gastroenterology (1983) 1.32
Australia antigen-antibody complexes. Nature (1970) 1.32
Comparison by studies in squirrel monkeys, chimpanzees, and adult humans of avian-human influenza A virus reassortants derived from different avian influenza virus donors. J Clin Microbiol (1986) 1.32
Experimental respiratory syncytial virus pneumonia in cebus monkeys. J Med Virol (1978) 1.30
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody. J Clin Microbiol (1982) 1.26
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res (1991) 1.25
Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees. J Clin Microbiol (1991) 1.24
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun (1977) 1.22
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Evaluation of the A/Seal/Mass/1/80 virus in squirrel monkeys. Infect Immun (1983) 1.20
Specificities of human antibodies to Australia antigen. Proc Soc Exp Biol Med (1970) 1.20
Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys. J Infect Dis (1986) 1.19
HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology (1991) 1.19
Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants. Infect Immun (1979) 1.18
Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol (1988) 1.14
Neutrophil function in children who are carriers of hepatitis-B surface antigen. Lancet (1977) 1.14
An attempt to produce chronic nitrite toxicosis in swine. J Am Vet Med Assoc (1967) 1.14
Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J Infect Dis (1994) 1.13
Persistence of hepatitis B surface antigen in the bedbug Cimex hemipterus (Fabr.). J Infect Dis (1979) 1.13
Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet (1976) 1.13
Australia antigen: detection and transmission in shellfish. Science (1974) 1.13
Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus. J Virol (1985) 1.12
Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention. Hum Pathol (1981) 1.12
Epizootiology, transmission and approach to prevention of fatal simian haemorrhagic fever in rhesus monkeys. Nature (1977) 1.12
Microbiological, serological, and histopathological features of experimental Chlamydia trachomatis urethritis in chimpanzees. Br J Vener Dis (1981) 1.11
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Lancet (1976) 1.10
Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer (2001) 1.10
Molecular clones of SIVsm and SIVagm: experimental infection of macaques and African green monkeys. J Med Primatol (1990) 1.09
Hepatitis B virus and antigen-antibody complex diseases. N Engl J Med (1977) 1.08
Differences among isolates of simian hemorrhagic fever (SHF) virus. Proc Soc Exp Biol Med (1986) 1.08
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis (1983) 1.08
Effects of host and environment on immunoglobulins in Down's syndrome. Arch Intern Med (1969) 1.07
Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. Cancer (1982) 1.06
Australia antigen and antibody in transfused children with thalassaemia. Arch Dis Child (1972) 1.06
Characterization of the M protein and nucleoprotein genes of an avian influenza A virus which are involved in host range restriction in monkeys. Vaccine (1989) 1.05
Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection. J Med Virol (1978) 1.05
Transmission of simian AIDS with type D retrovirus isolate. Lancet (1984) 1.05
Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis (1997) 1.04